These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16036800)

  • 1. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy.
    Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD
    J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
    Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
    J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Paglia MG; Gentile M; Cingolani A; Murri R; Liuzzi G; Monforte AD; Antinori A
    J Infect Dis; 2000 Oct; 182(4):1077-83. PubMed ID: 10979902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy.
    Marzocchetti A; Di Giambenedetto S; Cingolani A; Ammassari A; Cauda R; De Luca A
    J Clin Microbiol; 2005 Aug; 43(8):4175-7. PubMed ID: 16081969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.
    Gasnault J; Kousignian P; Kahraman M; Rahoiljaon J; Matheron S; Delfraissy JF; Taoufik Y
    J Neurovirol; 2001 Aug; 7(4):375-81. PubMed ID: 11517420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
    Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
    Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
    Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
    J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
    Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
    J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.
    McGuire D; Barhite S; Hollander H; Miles M
    Ann Neurol; 1995 Mar; 37(3):395-9. PubMed ID: 7695239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy.
    Yiannoutsos CT; Major EO; Curfman B; Jensen PN; Gravell M; Hou J; Clifford DB; Hall CD
    Ann Neurol; 1999 Jun; 45(6):816-21. PubMed ID: 10360779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progressive multifocal leukoencephalopathy revealing AIDS in a 13-year-old girl].
    Hugonenq C; Lethel V; Chambost H; Michel G; Chabrol B; Mancini J
    Arch Pediatr; 2002 Jan; 9(1):32-5. PubMed ID: 11865546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
    Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
    Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for AIDS patients with progressive multifocal leukoencephalopathy.
    Hernández B; Dronda F; Moreno S
    Expert Opin Pharmacother; 2009 Feb; 10(3):403-16. PubMed ID: 19191678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
    Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
    Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
    Kishida S
    No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.